Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 21980540)

1.

Innovative partnerships for drug discovery against neglected diseases.

Jakobsen PH, Wang MW, Nwaka S.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1221. doi: 10.1371/journal.pntd.0001221. Epub 2011 Sep 27. No abstract available.

2.

Progress in public-private partnerships to fight neglected diseases.

Gustavsen K, Hanson C.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1745-9. doi: 10.1377/hlthaff.28.6.1745.

3.

Drugs for neglected diseases: part II.

Kaneko T.

Future Med Chem. 2011 Sep;3(11):1329-30. doi: 10.4155/fmc.11.104. No abstract available.

4.

Interview with Solomon Nwaka.

Nwaka S.

Future Med Chem. 2011 Sep;3(11):1339-44. doi: 10.4155/fmc.11.99.

5.

Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.

Ioset JR, Chang S.

Future Med Chem. 2011 Sep;3(11):1361-71. doi: 10.4155/fmc.11.102.

PMID:
21879842
6.

Drug discovery and development for neglected diseases: the DNDi model.

Chatelain E, Ioset JR.

Drug Des Devel Ther. 2011 Mar 16;5:175-81. doi: 10.2147/DDDT.S16381. Review.

7.

The importance of patent sharing in neglected disease drug discovery.

Edlin C.

Future Med Chem. 2011 Sep;3(11):1331-4. doi: 10.4155/fmc.11.101. No abstract available.

8.

Traditional drug-discovery model ripe for reform.

Cressey D.

Nature. 2011 Mar 3;471(7336):17-8. doi: 10.1038/471017a. No abstract available. Erratum in: Nature. 2011 Mar 10;471(7337):150.

PMID:
21368796
9.

Development assistance for neglected tropical diseases: progress since 2009.

Liese BH, Houghton N, Teplitskaya L.

Int Health. 2014 Sep;6(3):162-71. doi: 10.1093/inthealth/ihu052. Epub 2014 Aug 5. Review.

PMID:
25096331
10.

Informatics for neglected diseases collaborations.

Bost F, Jacobs RT, Kowalczyk P.

Curr Opin Drug Discov Devel. 2010 May;13(3):286-96. Review.

PMID:
20443162
11.

Integrated dataset of screening hits against multiple neglected disease pathogens.

Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, Cho-Ngwa F, Samje M, Misra-Bhattacharya S, Murthy PK, Fakorede F, Paris JM, Yeates C, Ridley R, Van Voorhis WC, Geary T.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1412. doi: 10.1371/journal.pntd.0001412. Epub 2011 Dec 20.

12.

Drug discovery for infectious agents causing neglected diseases.

Silber AM, Pereira CA, Wrenger C.

Curr Med Chem. 2014;21(15):1667. No abstract available.

PMID:
24304273
13.

A kernel for open source drug discovery in tropical diseases.

Ortí L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, Rai AK, Taylor G, Todd MH, Pineda-Lucena A, Sali A, Marti-Renom MA.

PLoS Negl Trop Dis. 2009;3(4):e418. doi: 10.1371/journal.pntd.0000418. Epub 2009 Apr 21.

14.

Control of neglected tropical diseases in Burundi: partnerships, achievements, challenges, and lessons learned after four years of programme implementation.

Ndayishimiye O, Ortu G, Soares Magalhaes RJ, Clements A, Willems J, Whitton J, Lancaster W, Hopkins A, Fenwick A.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2684. doi: 10.1371/journal.pntd.0002684. eCollection 2014 May. No abstract available.

15.

Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.

Stefanakis R, Robertson AS, Ponder EL, Moree M.

PLoS Negl Trop Dis. 2012;6(10):e1803. doi: 10.1371/journal.pntd.0001803. Epub 2012 Oct 25. Review. No abstract available.

16.

The role of product development partnerships in advancing the development of drugs for unmet needs.

Breitstein J, Spigelman M.

Clin Pharmacol Ther. 2013 Jun;93(6):468-70. doi: 10.1038/clpt.2013.53. No abstract available.

PMID:
23689211
17.

Has the NTD community neglected evidence-based policy?

Nagpal S, Sinclair D, Garner P.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2238. doi: 10.1371/journal.pntd.0002238. Print 2013. No abstract available.

18.

Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.

Johnston KL, Ford L, Taylor MJ.

J Biomol Screen. 2014 Mar;19(3):335-43. doi: 10.1177/1087057113511270. Epub 2013 Nov 15. Review.

PMID:
24241712
19.

Linking global HIV/AIDS treatments with national programs for the control and elimination of the neglected tropical diseases.

Noblick J, Skolnik R, Hotez PJ.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1022. doi: 10.1371/journal.pntd.0001022. Epub 2011 Jul 26. No abstract available.

20.

Transgenic parasites accelerate drug discovery.

Rodriguez A, Tarleton RL.

Trends Parasitol. 2012 Mar;28(3):90-2. doi: 10.1016/j.pt.2011.12.003. Epub 2012 Jan 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk